BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 17485206)

  • 21. 5-Cyclic amine-3-arylsulfonylindazoles as novel 5-HT6 receptor antagonists.
    Haydar SN; Yun H; Andrae PM; Mattes J; Zhang J; Kramer A; Smith DL; Huselton C; Graf R; Aschmies S; Schechter LE; Comery TA; Robichaud AJ
    J Med Chem; 2010 Mar; 53(6):2521-7. PubMed ID: 20170099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity.
    Medina RA; Sallander J; Benhamú B; Porras E; Campillo M; Pardo L; López-Rodríguez ML
    J Med Chem; 2009 Apr; 52(8):2384-92. PubMed ID: 19326916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel 1-(azacyclyl)-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines as 5-HT6 agonists and antagonists.
    Elokdah H; Li D; McFarlane G; Bernotas RC; Robichaud AJ; Magolda RL; Zhang GM; Smith D; Schechter LE
    Bioorg Med Chem; 2007 Sep; 15(18):6208-26. PubMed ID: 17624788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bicyclic piperazinylbenzenesulphonamides are potent and selective 5-HT6 receptor antagonists.
    Bromidge SM; Clarke SE; King FD; Lovell PJ; Newman H; Riley G; Routledge C; Serafinowska HT; Smith DR; Thomas DR
    Bioorg Med Chem Lett; 2002 May; 12(10):1357-60. PubMed ID: 11992776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and characterization of the first fluorescent antagonists for human 5-HT4 receptors.
    Berque-Bestel I; Soulier JL; Giner M; Rivail L; Langlois M; Sicsic S
    J Med Chem; 2003 Jun; 46(13):2606-20. PubMed ID: 12801225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (Phenylpiperazinyl-butyl)oxindoles as selective 5-HT7 receptor antagonists.
    Volk B; Barkóczy J; Hegedus E; Udvari S; Gacsályi I; Mezei T; Pallagi K; Kompagne H; Lévay G; Egyed A; Hársing LG; Spedding M; Simig G
    J Med Chem; 2008 Apr; 51(8):2522-32. PubMed ID: 18361484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conformationally constrained N1-arylsulfonyltryptamine derivatives as 5-HT6 receptor antagonists.
    Cole DC; Lennox WJ; Stock JR; Ellingboe JW; Mazandarani H; Smith DL; Zhang G; Tawa GJ; Schechter LE
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4780-5. PubMed ID: 16125933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 8-Sulfonyl-substituted tetrahydro-1H-pyrido[4,3-b]indoles as 5-HT6 receptor antagonists.
    Ivachtchenko AV; Mitkin OD; Tkachenko SE; Okun IM; Kysil VM
    Eur J Med Chem; 2010 Feb; 45(2):782-9. PubMed ID: 19939513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a novel series of 3-piperidinyl-5-sulfonylindazoles as potent 5-HT6 ligands.
    Liu KG; Lo JR; Comery TA; Zhang GM; Zhang JY; Kowal DM; Smith DL; Di L; Kerns EH; Schechter LE; Robichaud AJ
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3214-6. PubMed ID: 19433358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 8-Piperazinyl-2,3-dihydropyrrolo[3,2-g]isoquinolines: potent, selective, orally bioavailable 5-HT1 receptor ligands.
    Heightman TD; Gaster LM; Pardoe SL; Pilleux JP; Hadley MS; Middlemiss DN; Price GW; Roberts C; Scott CM; Watson JM; Gordon LJ; Holland VA; Powles J; Riley GJ; Stean TO; Trail BK; Upton N; Austin NE; Ayrton AD; Coleman T; Cutler L
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4370-4. PubMed ID: 16039851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of cycloalkane-annelated 3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidines and their evaluation as 5-HT6 receptor antagonists.
    Ivachtchenko AV; Dmitriev DE; Golovina ES; Dubrovskaya ES; Kadieva MG; Koryakova AG; Kysil VM; Mitkin OD; Tkachenko SE; Okun IM; Vorobiov AA
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2133-6. PubMed ID: 20207539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of novel indanylsulfonamide guanylhydrazones as potent 5-HT6 serotonin receptor antagonists.
    Mesquida N; López-Pérez S; Dinarès I; Frigola J; Mercè R; Holenz J; Pérez R; Burgueño J; Alcalde E
    J Med Chem; 2009 Oct; 52(19):6153-7. PubMed ID: 19739674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tricyclic azepine derivatives as selective brain penetrant 5-HT6 receptor antagonists.
    Trani G; Baddeley SM; Briggs MA; Chuang TT; Deeks NJ; Johnson CN; Khazragi AA; Mead TL; Medhurst AD; Milner PH; Quinn LP; Ray AM; Rivers DA; Stean TO; Stemp G; Trail BK; Witty DR
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5698-700. PubMed ID: 18793848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of 3-aryl-3-methyl-1H-quinoline-2,4-diones as a new class of selective 5-HT6 receptor antagonists.
    Seong CM; Park WK; Park CM; Kong JY; Park NS
    Bioorg Med Chem Lett; 2008 Jan; 18(2):738-43. PubMed ID: 18053713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pyridinol derivatives (4). Synthesis and pharmacological actions of 3,4-dihydro-2H-pyrido[3,2-b]-1,4-oxazine derivatives. (1)].
    Takeda H; Hisamichi K; Fujita H; Muroga S; Suzuki S
    Yakugaku Zasshi; 1983 May; 103(5):497-507. PubMed ID: 6644543
    [No Abstract]   [Full Text] [Related]  

  • 36. Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders.
    Heal DJ; Smith SL; Fisas A; Codony X; Buschmann H
    Pharmacol Ther; 2008 Feb; 117(2):207-31. PubMed ID: 18068807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of 3,4-dihydro-2H-benzo[1,4]oxazine derivatives as dual thromboxane A2 receptor antagonists and prostacyclin receptor agonists.
    Ohno M; Tanaka Y; Miyamoto M; Takeda T; Hoshi K; Yamada N; Ohtake A
    Bioorg Med Chem; 2006 Mar; 14(6):2005-21. PubMed ID: 16297632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and serotonergic activity of variously substituted (3-amido)phenylpiperazine derivatives and benzothiophene-4-piperazine derivatives: novel antagonists for the vascular 5-HT1B receptor.
    Moloney GP; Garavelas A; Martin GR; Maxwell M; Glen RC
    Eur J Med Chem; 2004 Apr; 39(4):305-21. PubMed ID: 15072840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In the search for selective ligands of 5-HT5, 5-HT6 and 5-HT7 serotonin receptors.
    Wesołowska A
    Pol J Pharmacol; 2002; 54(4):327-41. PubMed ID: 12523486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies toward the discovery of the next generation of antidepressants. Part 5: 3,4-Dihydro-2H-benzo[1,4]oxazine derivatives with dual 5-HT1A receptor and serotonin transporter affinity.
    Zhou D; Harrison BL; Shah U; Andree TH; Hornby GA; Scerni R; Schechter LE; Smith DL; Sullivan KM; Mewshaw RE
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1338-41. PubMed ID: 16332439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.